Skip to main content
EssilorLuxottica logo

EssilorLuxottica — Investor Relations & Filings

Ticker · EL ISIN · FR0014007HJ5 LEI · 549300M3VH1A3ER1TB49 PA Manufacturing
Open in API
Filings indexed 1,139 across all filing types
Latest filing 2023-07-13 Call Transcript
Country FR France
Listing PA EL

About EssilorLuxottica

https://www.essilorluxottica.com/

EssilorLuxottica is a global leader in the design, manufacture, and distribution of ophthalmic lenses, prescription frames, and sunglasses. The company operates a vertically integrated business model, managing a comprehensive portfolio of proprietary and licensed eyewear and vision care brands. Its activities encompass the production of advanced vision care products, including lenses and optical instruments, as well as a wide range of eyewear. EssilorLuxottica distributes its products through a global network of wholesale and retail channels, serving consumers with solutions for their vision needs and personal style.

Recent filings

Filing Released Lang Actions
EssilorLuxottica: Second-Quarter and First-Half 2023 Results Conference Call Invitation
Call Transcript Classification · 98% confidence The document is explicitly titled "Second-Quarter and First-Half 2023 Results Conference Call Invitation." It invites recipients to a conference call to discuss the results, provides dial-in details, and mentions that the press release and presentation slides will be made available prior to the call. This content is an invitation and logistical announcement related to an earnings discussion, which strongly aligns with the definition of a Call Transcript (CT) event, even though this document is the invitation rather than the transcript itself. However, since the document is an invitation to a conference call where results will be discussed, and the definition for CT is 'Full text transcript of company conference calls (like earnings calls with Q&A)', this invitation is the precursor to the CT. Given the options, the most relevant category for an earnings-related call announcement is CT, as it pertains directly to the event where the earnings discussion (which would generate a CT) takes place. If 'RPA' (Report Publication Announcement) was used, it would typically be for announcing the release of a formal report (like 10-K or IR), not the call itself. Therefore, CT is the best fit for an earnings call invitation.
2023-07-13 English
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2023
Share Issue/Capital Change Classification · 95% confidence The document is titled "Nombre total de droits de vote et d'actions composant le capital social au 30 juin 2023" (Total number of voting rights and shares comprising the share capital as of June 30, 2023). It explicitly references French commercial code and AMF regulations, and provides a precise breakdown of the total number of shares and voting rights as of a specific date (June 30, 2023). This type of mandatory disclosure regarding the capital structure and voting rights is typically associated with regulatory filings concerning share ownership or capital changes. While it relates to capital structure, it is not a general financing announcement (CAP) or a report of the company buying back shares (POS). It is a formal declaration of the current share count, which often accompanies or is required alongside major corporate actions or periodic reporting. Given the options, this specific disclosure about the total number of shares and voting rights, often required by regulators like the AMF, fits best under the general category of regulatory reporting that isn't covered by more specific codes like 10-K or ER. However, since it details the composition of the capital, it is closely related to share structure changes. If a specific code for 'Share Capital Disclosure' existed, it would fit there. Among the provided codes, 'SHA' (Share Issue/Capital Change) is the closest thematic fit, as it reports the current state of the capital base. Alternatively, if this is a standalone mandatory filing that doesn't fit elsewhere, 'RNS' (Regulatory Filings) is the fallback. Given the precise nature of the data (total shares/votes), it is a specific regulatory disclosure. Since it is a formal, dated disclosure of the capital structure, and not an announcement of a transaction (like a buyback or new issue), it is best classified as a specific regulatory disclosure. In many jurisdictions, this is a required periodic filing. I will classify it as 'RNS' as the most appropriate general regulatory filing category when a more specific one (like a proxy statement or earnings report) is not applicable, although it touches upon capital structure.
2023-07-06 French
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2023" and explicitly references French regulatory articles (Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers - AMF). It provides a precise breakdown of the number of shares outstanding and the corresponding voting rights as of a specific date (June 30, 2023). This content directly relates to the official reporting of ownership structure and voting power, which falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA). It is not an AGM presentation, a full annual report (10-K), or a general earnings release (ER).
2023-07-06 English
EssilorLuxottica and Jimmy Choo announce a ten-year licensing agreement
Regulatory Filings Classification · 100% confidence The document is a press release announcing a significant business event: a ten-year exclusive licensing agreement between EssilorLuxottica and Jimmy Choo for eyewear. This type of announcement, detailing a strategic partnership, merger proposal, or major transaction, aligns best with the M&A Activity (TAR) category, as it involves a significant commercial transaction between two entities, even if it's a licensing deal rather than a full takeover. It is not a standard financial report (10-K, IR, ER) or a management change (MANG). Given the nature of combining business operations/rights, TAR is the most appropriate fit among the provided options.
2023-06-29 English
EssilorLuxottica et Jimmy Choo annoncent un accord de licence pour dix ans
Regulatory Filings Classification · 100% confidence The document announces a significant business event: the signing of a ten-year exclusive licensing agreement between EssilorLuxottica and Jimmy Choo for eyewear. This type of announcement, detailing a major partnership, financing structure change, or strategic move, most closely aligns with the 'Capital/Financing Update' (CAP) category if it involves capital structure or fundraising, or potentially 'Regulatory Filings' (RNS) if it's a mandatory disclosure. However, since the core content is about a strategic business transaction (licensing agreement) that impacts future operations and potentially the capital structure or business scope, and it is not a standard financial report (10-K, IR, ER), it fits best under a category related to major corporate actions. Given the options, this is a significant corporate transaction announcement. It is not a standard earnings release (ER), interim report (IR), or a simple management change (MANG). It is not a proxy statement (PSI) or a director's dealing (DIRS). Since it details a major agreement that affects the business structure and future revenue streams, and it is not explicitly covered by other specific codes like M&A (TAR), the most appropriate classification among the provided options for a major strategic partnership announcement that isn't a standard financial report is often the general 'Regulatory Filings' (RNS) or, if interpreted as a major strategic shift impacting financing/operations, 'CAP'. Given the nature of a licensing deal, which is a strategic business agreement, and lacking a specific 'Strategic Partnership' code, RNS serves as the best general regulatory disclosure fallback. However, if we strictly interpret the definitions, this is a major corporate event announcement. Since it is not a report itself, and it's a specific announcement, RNS is the safest fallback. If we consider it a major change in business scope/structure, it could be argued for CAP, but CAP is defined as fundraising/financing activities. Therefore, RNS (General Regulatory Announcement) is the most suitable fit for a non-standard, material corporate announcement.
2023-06-29 French
EssilorLuxottica: Result of the payment of dividends in shares and record of the corresponding capital increase
Notice of Dividend Amount Classification · 99% confidence The document explicitly details the 'Result of the payment of dividends in shares and record of the corresponding capital increase.' It discusses the option given to shareholders to receive dividends in shares, the price set for new shares, the number of rights exercised, the issuance of new shares (5,909,082), and the total cash dividend amount. This content directly relates to the distribution of dividends and the resulting change in share capital. The most fitting category is 'Notice of Dividend Amount' (DIV) or potentially 'Share Issue/Capital Change' (SHA). Since the primary focus is the outcome of the dividend election which results in a share issuance, and it is a specific announcement about dividend payment details, DIV is highly relevant. However, the issuance of new shares (1.32% of capital) is a significant capital structure event. Given the options, 'DIV' covers the dividend aspect, while 'SHA' covers the capital change aspect. Since the announcement is triggered by the dividend decision and details the payment mechanism, 'DIV' is a strong candidate. Alternatively, because it involves the issuance of new shares, 'SHA' is also plausible. Let's re-evaluate the definitions. DIV is 'Announcement of dividend amounts, payment dates, and details for shareholders.' SHA is 'Announcement regarding new share issues, stock splits, or other capital changes.' This document covers both the dividend payment details AND the resulting new share issuance. Since the issuance of new shares is a direct consequence and a major part of the announcement, SHA might be slightly more encompassing of the capital structure change described. However, the context starts with the dividend result. Given the specific nature of dividend payment mechanics being detailed, DIV is appropriate. Let's check for a better fit. There is no specific code for 'Dividend Reinvestment Plan (DRIP) results'. Since new shares are being issued as a result of the dividend election, this is fundamentally a capital change announcement driven by a dividend event. I will classify this as SHA because the issuance of 5.9 million new shares is a concrete capital change event being reported, which is a core component of the filing. If SHA is too broad, DIV is the next best fit. Given the explicit mention of capital increase and new shares issued, SHA is the most precise fit for the structural change reported.
2023-06-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.